Search

Your search keyword '"Primary Prevention/methods"' showing total 2 results
Start Over Descriptor "Primary Prevention/methods" Publisher hal ccsd
2 results on '"Primary Prevention/methods"'

1. COVID-19: don't neglect antimicrobial stewardship principles!

Author

Benedikt Huttner, Céline Pulcini, Gaud Catho, José Ramón Paño-Pardo, Jeroen Schouten, Department of Infectious Diseases and Infection Control [Geneva, Switzerland], Hôpitaux Universitaires de Genève (HUG), Faculté de médecine [Genève], Hospital Clínico de Zaragoza, Maladies chroniques, santé perçue, et processus d'adaptation (APEMAC), Université de Lorraine (UL), Service des Maladies Infectieuses et Tropicales [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), and Nijmegen University Center for Infectious Diseases

Subjects
Antimicrobial Stewardship, 0302 clinical medicine, Coronavirus Infections/drug therapy/epidemiology, Pandemic, Medicine, Antimicrobial stewardship, 030212 general & internal medicine, Pneumonia, Viral/drug therapy/epidemiology, ComputingMilieux_MISCELLANEOUS, media_common, ddc:616, 0303 health sciences, biology, Viral Epidemiology, Critical Care/methods, General Medicine, Primary Prevention/methods, Anti-Bacterial Agents, Primary Prevention, Infectious Diseases, Antimicrobial Stewardship/methods, Coronavirus Infections, Superinfection/drug therapy, Microbiology (medical), 2019-20 coronavirus outbreak, Coronavirus disease 2019 (COVID-19), Critical Care, media_common.quotation_subject, Pneumonia, Viral, Bacteria/classification/isolation & purification, Article, Neglect, 03 medical and health sciences, Betacoronavirus, Humans, Pandemics, Bacteria, 030306 microbiology, business.industry, SARS-CoV-2, COVID-19, biology.organism_classification, medicine.disease, Virology, Anti-Bacterial Agents/therapeutic use, Pneumonia, Superinfection, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, business
Abstract

International audience

Published
2020
Full Text
View/download PDF

2. Implantation des défibrillateurs en prévention primaire dans la vraie vie: les principaux résultats de la phase pilote du programme DAIPP

Author

Pascal Defaye, Rui Providência, Pierre Bordachar, Nicolas Sadoul, Rodrigue Garcia, Kumar Narayanan, Eloi Marijon, Frankie Beganton, Didier Klug, Vincent Algalarrondo, Serge Boveda, Marie-Cécile Perier, Olivier Piot, Sophie Jacob, Jean-Claude Deharo, Sérgio Barra, Laurent Fauchier, Christophe Leclercq, Daniel Gras, Dominique Babuty, Institut de Radioprotection et de Sûreté Nucléaire (IRSN), and Clinical sciences

Subjects
Pilot phase, medicine.medical_specialty, Time Factors, Heart disease, medicine.medical_treatment, [SDV]Life Sciences [q-bio], Population, Electric Countershock, Pilot Projects, 030204 cardiovascular system & hematology, France/epidemiology, Sudden cardiac death, 03 medical and health sciences, 0302 clinical medicine, Primary prevention, medicine, Electric Countershock/instrumentation, Humans, Multicenter Studies as Topic, risk factors, In patient, 030212 general & internal medicine, Registries, Intensive care medicine, education, Death, Sudden, Cardiac/epidemiology, Retrospective Studies, education.field_of_study, business.industry, General Medicine, medicine.disease, Implantable cardioverter-defibrillator, Primary Prevention/methods, 3. Good health, Icd implantation, Defibrillators, Implantable, Primary Prevention, Death, Sudden, Cardiac, Treatment Outcome, France, business, Cardiology and Cardiovascular Medicine
Abstract

This review summarizes the main findings of the French multicentre DAI-PP pilot programme, and discusses the related clinical and research perspectives. This project included retrospectively (2002–2012 period) more than 5000 subjects with structural heart disease who received an implantable cardioverter defibrillator (ICD) for primary prevention of sudden cardiac death, and were followed for a mean period of 3 years. The pilot phase of the DAI-PP programme has provided valuable information on several practical and clinically relevant aspects of primary prevention ICD implantation in the real-world population, which are summarized in this review. This pilot has led to a prospective evaluation that started in May 2018, assessing ICD therapy in primary and secondary prevention in patients with structural and electrical heart diseases, with remote monitoring follow-up using a dedicated platform. This should further enhance our understanding of sudden cardiac death, to eventually optimize the field of preventative actions. © 2019 Elsevier Masson SAS; Cet article résume les principaux résultats de la phase pilote du programme DAI-PP et discute ses perspectives scientifiques. Ce projet a inclus plus de 5000 sujets (pendant la période 2002–2012) ayant une cardiopathie et implantés d’un défibrillateur automatique implantable (DAI) en prévention primaire de la mort subite avec un suivi moyen de 3 ans. Cette évaluation pilote du programme de recherche DAI-PP, mené dans la vraie vie, a permis d'identifier des messages importants concernant la prévention primaire de la mort subite de patients porteurs de cardiomyopathies dilatées ou cardiopathies ischémiques, résumés dans cet article. Cette phase préliminaire a également permis l'initiation d'une évaluation prospective, débutée en mai 2018, avec pour ambition d'évaluer la prévention primaire et secondaire quelque soit le phénotype sous jacent (structurel ou électrique), en utilisant une nouvelle plateforme de télésurveillance. DAI-PP devrait permettre de mieux comprendre différents aspects de la mort subite cardiaque, pour au final en améliorer la prévention.

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results